Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT02792270
Status
Recruiting

Conditions

  • Tumor Surgery

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Caloric Restriction Diet — OTHER
    Two nutritional supplements, one from Ensure (Abbott Laboratories, Chicago, IL) and one from Boost (Nestle, Vevey, Switzerland) will be used for 3 days before surgery. The supplements are the Ensure Pre-Surgery Clear Carbohydrate Drink and the Ensure Original Nutrition Powder. The Original Nutrition Powder will be mixed with 8oz of water, oat milk, or almond milk. The proposed macronutrient profile for the 3 days of caloric restriction (CR) is less than 8% of calories from protein.

Study Details

This study is being conducted to decrease the rate of surgical wound complications. The investigators are studying the effects that caloric restriction has on decreasing the rate of surgical wound complications.

Key Dates

Start date
Jun 30, 2016
Status verified
May 2026
Primary completion
Aug 31, 2026
Completion
May 31, 2027

Study Design

Enrollment
32 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Caloric Restriction Diet
    Patients will meet with the Registered Dietitian to discuss calorie, protein, and fluid needs.The dietitian will calculate calorie needs. * Calorie needs will be reduced by 30%. * Protein needs will be estimated based on 0.8g/kg BW and then reduced by 70%. * Dietitian will educate participants on electrolytes and fluid intake based on the reduced food intake.
  • No Intervention: Normal Diet
    Participant will follow a normal diet.

Primary Outcome Measure

Change In The Rate Of Physical Function By MSTS [ Time Frame: Baseline, 6 weeks, 3 months and 6 months visits after surgery ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts general HospitalBostonMassachusetts02114
Santiago A Lozano-Calderón, MD, PhD
617-643-4947
Shreya Halur, BS
617-726-4932
Santiago A Lozano-Calderón, MD,PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA